Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6,6'-oxybis(2,2-dimethylhexanoic Acid)
2. Pd 72953
3. Pd72953
1. 183293-82-5
2. Gemcabene [inn]
3. Pd-72953
4. B96ux1ddks
5. 6,6'-oxybis(2,2-dimethylhexanoic Acid)
6. Hexanoic Acid, 6,6'-oxybis[2,2-dimethyl-
7. Unii-b96ux1ddks
8. 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethyl-hexanoic Acid
9. Pd 72953
10. 6,6'-oxybis(2,2-dimethylhexanoic) Acid
11. Schembl761631
12. 6-(5-carboxy-5-methylhexoxy)-2,2-dimethylhexanoic Acid
13. Chembl2110686
14. Dtxsid60171407
15. Bcp34011
16. Zinc1893031
17. Db05123
18. Pd72953
19. Ac-35730
20. Da-36793
21. Hy-109567
22. Cs-0031888
23. Ft-0743032
24. 2,2,2',2'-tetramethyl-6,6'-oxydihexanoic Acid
25. Hexanoic Acid, 6,6'-oxybis 2,2-dimethyl-
26. Q27095571
27. Pd72953; Pd 72953; Pd-72953
28. 6-(5-carboxy-5-methylhexoxy)-2,2-dimethyl-hexanoic Acid
| Molecular Weight | 302.41 g/mol |
|---|---|
| Molecular Formula | C16H30O5 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 12 |
| Exact Mass | 302.20932405 g/mol |
| Monoisotopic Mass | 302.20932405 g/mol |
| Topological Polar Surface Area | 83.8 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 302 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in atherosclerosis, cardiovascular disorders, and hyperlipidemia.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Gemcabene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gemcabene, including repackagers and relabelers. The FDA regulates Gemcabene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gemcabene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Gemcabene supplier is an individual or a company that provides Gemcabene active pharmaceutical ingredient (API) or Gemcabene finished formulations upon request. The Gemcabene suppliers may include Gemcabene API manufacturers, exporters, distributors and traders.
Gemcabene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gemcabene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gemcabene GMP manufacturer or Gemcabene GMP API supplier for your needs.
A Gemcabene CoA (Certificate of Analysis) is a formal document that attests to Gemcabene's compliance with Gemcabene specifications and serves as a tool for batch-level quality control.
Gemcabene CoA mostly includes findings from lab analyses of a specific batch. For each Gemcabene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gemcabene may be tested according to a variety of international standards, such as European Pharmacopoeia (Gemcabene EP), Gemcabene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gemcabene USP).
LOOKING FOR A SUPPLIER?
